{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:11:24Z","timestamp":1761894684157,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50CA89568"],"award-info":[{"award-number":["P50CA89568"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.urology.2007.11.049","type":"journal-article","created":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T18:27:11Z","timestamp":1204828031000},"page":"554-560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Body Composition and Serum Prostate-Specific Antigen: Review and Findings from Flint Men\u2019s Health Study"],"prefix":"10.1016","volume":"71","author":[{"given":"Jennifer L.","family":"Beebe-Dimmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary J.","family":"Faerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hal","family":"Morgenstern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Werny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirk","family":"Wojno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronwen","family":"Halstead-Nussloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A.","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2007.11.049_bib1","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM198710083171501","article-title":"Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate","volume":"317","author":"Stamey","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2007.11.049_bib2","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/cncr.20480","article-title":"Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker","volume":"101","author":"Hernandez","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2007.11.049_bib3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/jnci\/95.14.1027","article-title":"Prostate cancer and prostate-specific antigen: the more we know, the less we understand","volume":"95","author":"Thompson","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2007.11.049_bib4","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2007.11.049_bib5","first-page":"125","article-title":"Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification","volume":"78","author":"Ankerst","year":"2006","journal-title":"Arch Ital Urol Androl"},{"issue":"4 Pt 1","key":"10.1016\/j.urology.2007.11.049_bib6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/01.ju.0000139993.51181.5d","article-title":"The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?","volume":"172","author":"Stamey","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.11.049_bib7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/01.ju.0000135302.58378.ae","article-title":"Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins","volume":"172","author":"Freedland","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.11.049_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1200\/JCO.2004.03.132","article-title":"Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy","volume":"22","author":"Amling","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2007.11.049_bib9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0090-4295(01)01373-5","article-title":"Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy","volume":"58","author":"Amling","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urology.2007.11.049_bib10","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1158\/1055-9965.EPI-06-0477","article-title":"Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial","volume":"15","author":"Gong","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2007.11.049_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1158\/1055-9965.EPI-06-0754","article-title":"Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort","volume":"16","author":"Rodriguez","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"19 Pt 1","key":"10.1016\/j.urology.2007.11.049_bib12","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1158\/1078-0432.CCR-04-1977","article-title":"Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy","volume":"11","author":"Strom","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2007.11.049_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/cncr.22443","article-title":"Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality","volume":"109","author":"Wright","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2007.11.049_bib14","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/epirev\/mxm006","article-title":"Obesity and prostate cancer: making sense out of apparently conflicting data","volume":"29","author":"Freedland","year":"2007","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.urology.2007.11.049_bib15","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/cncr.20856","article-title":"The association of body mass index and prostate-specific antigen in a population-based study","volume":"103","author":"Baillargeon","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2007.11.049_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0090-4295(00)00873-6","article-title":"Age-specific distribution of serum prostate-specific antigen in a community-based study of African-American men","volume":"57","author":"Cooney","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urology.2007.11.049_bib17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0895-4356(00)00270-5","article-title":"Potential selection bias in a community-based study of PSA levels in African-American men","volume":"54","author":"Heeringa","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.urology.2007.11.049_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/bmj.311.6998.158","article-title":"Waist circumference as a measure for indicating need for weight management","volume":"311","author":"Lean","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.urology.2007.11.049_bib19","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.295.13.1549","article-title":"Prevalence of overweight and obesity in theUnited States, 1999\u20132004","volume":"295","author":"Ogden","year":"2006","journal-title":"JAMA"},{"issue":"11 suppl","key":"10.1016\/j.urology.2007.11.049_bib21","doi-asserted-by":"crossref","first-page":"S663","DOI":"10.1097\/00005768-199911001-00026","article-title":"Economic costs of obesity and inactivity","volume":"31","author":"Colditz","year":"1999","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.urology.2007.11.049_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archinte.164.3.249","article-title":"The escalating pandemics of obesity and sedentary lifestyle: a call to action for clinicians","volume":"164","author":"Manson","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.urology.2007.11.049_bib23","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.288.16.2008","article-title":"Platelet activation in obese women: role of inflammation and oxidant stress","volume":"288","author":"Davi","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2007.11.049_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1467-789X.2003.00108.x","article-title":"Central obesity and breast cancer risk: a systematic review","volume":"4","author":"Harvie","year":"2003","journal-title":"Obes Rev"},{"key":"10.1016\/j.urology.2007.11.049_bib25","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2007.11.049_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/eje.0.1500161","article-title":"Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women","volume":"150","author":"Lukanova","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.urology.2007.11.049_bib27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1158\/1055-9965.EPI-130-3","article-title":"Association between insulin-like growth factor-I: insulin-like growth factor-binding protein-1 ratio and metabolic and anthropometric factors in men and women","volume":"13","author":"Sandhu","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2007.11.049_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev.publhealth.26.021304.144402","article-title":"Advances in cancer epidemiology: understanding causal mechanisms and the evidence for implementing interventions","volume":"26","author":"Schottenfeld","year":"2005","journal-title":"Ann Rev Pub Health"},{"key":"10.1016\/j.urology.2007.11.049_bib29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1200\/JCO.2004.03.132","article-title":"Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy","volume":"22","author":"Amling","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2007.11.049_bib30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2004.04.181","article-title":"Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group","volume":"22","author":"Freedland","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2007.11.049_bib31","first-page":"345","article-title":"Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States","volume":"10","author":"Rodriguez","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2007.11.049_bib32","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2007.11.049_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.eururo.2007.04.069","article-title":"Obesity and prostate cancer: epidemiology and clinical implications","volume":"52","author":"Buschemeyer","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2007.11.049_bib34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djj131","article-title":"Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial","volume":"98","author":"Thompson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2007.11.049_bib35","first-page":"1","article-title":"Prostate cancer screening practices and cancer control research (United States)","volume":"13","author":"Schottenfeld","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.urology.2007.11.049_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/pros.2990270503","article-title":"Prostate specific antigen in a community-based sample of men without prostate cancer: correlations with prostate volume, age, body mass index, and symptoms of prostatism","volume":"27","author":"Bosch","year":"1995","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2007.11.049_bib37","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0022-5347(01)62395-4","article-title":"Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men","volume":"160","author":"Smith","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2007.11.049_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1078-1439(03)00171-6","article-title":"Relationship of body mass index and prostate specific antigen in a population-based study","volume":"22","author":"Thompson","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2007.11.049_bib39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/cncr.21603","article-title":"Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase","volume":"106","author":"Kristal","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2007.11.049_bib40","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/cncr.22249","article-title":"Effects of obesity and height on prostate specific antigen (PSA) and percentage of free PSA levels among African-American and Caucasian men","volume":"107","author":"Fowke","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2007.11.049_bib41","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.urology.2004.10.074","article-title":"Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program","volume":"65","author":"Barqawi","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2007.11.049_bib42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1158\/1055-9965.EPI-06-0588","article-title":"Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001\u20132004","volume":"16","author":"Werny","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urology.2007.11.049_bib43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0090-4295(02)02001-0","article-title":"Influence of age, anthropometry, and hepatic and renal function on serum prostate-specific antigen levels in healthy middle-age men","volume":"61","author":"Ku","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.urology.2007.11.049_bib44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.urology.2005.04.040","article-title":"Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer","volume":"66","author":"Ochiai","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2007.11.049_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.pcan.4500924","article-title":"The association between body size, prostate volume and prostate-specific antigen","volume":"10","author":"Fowke","year":"2007","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042950702420X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042950702420X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:48:23Z","timestamp":1758764903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042950702420X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S009042950702420X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2007.11.049","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Body Composition and Serum Prostate-Specific Antigen: Review and Findings from Flint Men\u2019s Health Study","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2007.11.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}